**Abstract**

**Objective:** Accumulating evidence suggests the role of Inflammation and oxidative stress in the pathophysiology of schizophrenia. Keap1-Nrf2 signaling plays an important role in the anti-inflammatory and anti-oxidant effects. Sulforaphane (SFN), a potent Nrf2 activator, has a potent anti-inflammatory and anti-oxidant activity. It is reported that SFN could attenuate behavioral abnormalities in mice after administration of methamphetamine or phencyclidine. The objective of this study was undertaken to examine whether glucoraphanin (a glucosinolate precursor of SFN) can prevent the onset of schizophrenia-like behavioral abnormalities in the offspring after maternal immune activation.

**Methods:** The synthetic double strand RNA polyriboinosinic-polyribocytidilic acid (poly I:C; 5.0 mg/kg) or saline were injected into pregnant ddY mice (E12 -- E17). The offspring were separated from their mothers after 3 weeks, and male mice were used in the subsequent experiments. Mice (4-weeks old) were divided into a normal food pellet group and a 0.1% glucoraphanin containing pellet group for 4-weeks. Then, normal food pellet was given to the all groups for 2-weeks, and behavioral tests (locomotion, novel object recognition test) were performed at 10-weeks old.

**Results:** In the novel object recognition test, the offspring from poly I:C-treated group showed cognitive deficits at adulthood. Interestingly, the dietary intake of 0.1% glucoraphanin during 4 -- 8 weekd old could prevent the onset of cognitive deficits at adulthood.

**Conclusion:** This study suggests that SFN can prevent the onset of behavioral abnormalities at adulthood in the immune activation model of schizophrenia. Therefore, the dietary intake of SFN-rich broccoli sprouts in subjects at a high-risk of developing psychosis may prevent the onset of psychosis at adulthood.
